The Executive Director of the Asset Development Team at 539 is responsible for leading the strategy and execution of drug development activities for oncology products, ensuring alignment across scientific, commercial, and manufacturing sectors. The ideal candidate will have significant experience in drug development and clinical trial management, particularly in oncology, with a strong focus on strategic leadership and regulatory interactions.
Base: $310,900.00 - $489,400.00; Bonus/Equity: Annual bonus and long-term incentive eligible; Benefits: Medical, dental, vision, 401(k), paid holidays, vacation
Must-have
Nice-to-have
Not specified